NKF, RenalytixAI partner to improve kidney disease diagnosis
Click Here to Manage Email Alerts
The National Kidney Foundation has formed a partnership with RenalytixAI to improve kidney disease diagnosis and assessment in early stages of the disease.
The agreement includes the launch of two pilot programs that will combine clinical expertise and a review of best practices, as well as look upstream at how to manage diabetes and hypertension.
Those findings will be published and shared during the American Society of Nephrology’s Kidney Week in 2021 and the NKF’s Spring Clinicals Meeting in 2022, according to a press release from the NKF.
“We must reach people early in their disease in order to slow or even stop the progression,” NKF CEO Kevin Longino, who is also a kidney transplant recipient, said in the release. “As a result of this collaboration, we believe lives will be improved and saved.”
RenalytixAI will collaborate on studies to assess current care standards in early stage kidney disease and identify barriers to better care and opportunities for improvement. Long-term initiatives will be developed as the partnership unfolds, the NKF said.
KidneyIntelX is an in-vitro diagnostic platform that uses a machine-learning enabled algorithm to interpret proprietary biomarkers from a simple blood draw and electronic health record features to generate a patient-specific risk score for disease progression. The score categorizes a patient as low, intermediate or high risk for kidney disease progression and kidney failure, according to the press release.
“This partnership with RenalytixAI will potentially improve kidney risk stratification, using artificial intelligence to evaluate the combination of important kidney function biomarkers and electronic health record information more accurately than measuring biomarkers alone,” NKF Chief Medical Officer Joseph Vassalotti, MD, said in the release. “This kidney disease severity information is designed to help Americans living with early stages of kidney disease partner with their primary care clinicians to consider which interventions best fit their individualized risk of kidney failure, including lifestyle modifications, kidney protective medications and whether or not interdisciplinary care with a dietitian and kidney specialist is necessary.”
Read more about
Click Here to Manage Email Alerts